Author

S. R. Williamson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Assay:imaging· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

D. A. Chitale· 2 shared H. Stricker· 2 shared J. Li· 2 shared J. O. Peabody· 2 shared N. Palanisamy· 2 shared N. S. Gupta· 2 shared P. D. Arachchige· 2 shared S. Carskadon· 2 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. A. Chitale

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization

N. Palanisamy, P. D. Arachchige, S. Carskadon, J. Li, I. Loveless, M. Alhamar, J. O. Peabody, H. Stricker, D. A. Chitale, C. G. Rogers, M. Menon, T. A. Bismar, N. S. Gupta, S. R. Williamson

The paper evaluates molecular heterogeneity in prostate cancer biopsy samples using dual immunohistochemistry and RNA in situ hybridization, finding clonal differences and higher heterogeneity in African American patients.

bioRxiv · Oct 25, 2019Cancer Biology

Pseudogene associated recurrent gene fusion in prostate cancer

B. V. Chakravarthi, P. D. Arachchige, S. Carskadon, S. Kalyana-Sundaram, J. Li, K.-H. H. Wu, D. S. Chandrashekar, J. O. Peabody, H. Stricker, C. Hwang, D. A. Chitale, S. R. Williamson, N. S. Gupta, N. M. Navone, C. Rogers, , N. Palanisamy

The paper identifies and validates a novel gene fusion in prostate cancer involving KLK4 and KLKP1, showing its association with high Gleason grade tumors and potential as a biomarker.

bioRxiv · Jun 11, 2019Cancer Biology